BioSpace News Archive

Deals

NBE-Therapeutics Closes USD 22M Series C Financing Round

NBE-Therapeutics AG announces the closing of a USD 22M Series C financing round, led by its existing shareholders Boehringer Ingelheim Venture Fund and the PPF Group and with participation from all private shareholders.

January 14, 2020
·
4 min read
Business

Adaptimmune and Astellas to Co-Develop Allogenic CAR-T and TCR T-Cell Therapies

Helen Tayton-Martin, Adaptimmune’s chief business officer and co-founder, said the partnership with Astellas builds upon and extends an existing collaboration focused on gene editing of iPSC cells.

January 14, 2020
·
3 min read
·
Alex Keown
Drug Development

AbbVie’s Skyrizi Beats Out Novartis’ Cosentyx in Plaque Psoriasis

AbbVie reported that its Skyrizi met both primary and all ranked secondary endpoints in its Phase III trial that went head-to-head with Novartis’ Cosentyx in plaque psoriasis.

January 14, 2020
·
3 min read
·
Mark Terry
FDA

GSK’s CEO Predicts Six Drug Approvals for the Company in 2020

Emma Walmsley, chief executive officer of GlaxoSmithKline, is predicting a good year for her company, with the potential of six regulatory approvals in the United States.

January 14, 2020
·
3 min read
·
Alex Keown
Career Advice

Jump-Starting Your 2020 Job Search

While early January can still be a slow time for hiring as people get organized, once the middle of the month hits, it’s go time.

January 14, 2020
·
2 min read
·
Laura Brothers
Bio NC

With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans

With the 2020 elections looming though, and lawmakers across the country drafting legislation aimed at curbing price increases, some companies are carefully examining the landscape as they approach pricing.

January 14, 2020
·
3 min read
·
Alex Keown
Business

SubjectWell Begins International Expansion with presence in the United Kingdom, Ireland and South Africa

The risk-free clinical trials marketplace meets the needs of international global pharmaceuticals and sponsors by expanding the patient pool for all studies

January 14, 2020
·
1 min read
Genetown

TGaS Kicks Off 2020 with New Hire, Promotions

TGaS® Advisors, a division of TRINITY, announced a new hire and several promotions at the life sciences benchmarking and advisory services firm.

January 14, 2020
·
2 min read
Business

Ipsen Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer

Ipsen announced the appointment of Dr. Steven Hildemann as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance effective March 1, 2020.

January 14, 2020
·
7 min read
Business

Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies

Astellas will pay Adaptimmune an upfront payment, research funding, development and commercial milestones, and royalties on net sales on co-commercialized products

January 14, 2020
·
8 min read